2020
DOI: 10.3389/fmolb.2020.599059
|View full text |Cite
|
Sign up to set email alerts
|

Hierarchical Graph Representation of Pharmacophore Models

Abstract: For the investigation of protein-ligand interaction patterns, the current accessibility of a wide variety of sampling methods allows quick access to large-scale data. The main example is the intensive use of molecular dynamics simulations applied to crystallographic structures which provide dynamic information on the binding interactions in protein-ligand complexes. Chemical feature interaction based pharmacophore models extracted from these simulations, were recently used with consensus scoring approaches to … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 35 publications
0
1
0
Order By: Relevance
“…The six classical pharmacophore features classified are H-bond donors, H-bond acceptors, negative ionic, positive ionic, hydrophobic regions, and aromatic regions ( Figure 8 ). On top of that, less common features can also better characterise the chemical functionalities, such various metal binding locations are supported by LigandScout [ 243 , 244 , 245 , 246 ]. Constraints and restrictions can also be applied by introducing excluded volumes to the model to prevent ligands from occupying certain spaces (ligand-inaccessible) [ 247 ].…”
Section: Ligand-based Drug Designmentioning
confidence: 99%
“…The six classical pharmacophore features classified are H-bond donors, H-bond acceptors, negative ionic, positive ionic, hydrophobic regions, and aromatic regions ( Figure 8 ). On top of that, less common features can also better characterise the chemical functionalities, such various metal binding locations are supported by LigandScout [ 243 , 244 , 245 , 246 ]. Constraints and restrictions can also be applied by introducing excluded volumes to the model to prevent ligands from occupying certain spaces (ligand-inaccessible) [ 247 ].…”
Section: Ligand-based Drug Designmentioning
confidence: 99%